massive increase - looks indexation related. was trading only $3.60s prior to the indexation news. The fund managers have increased the price by over 25% in the past 2 weeks.
Expensive stock - circa p/e ratio has blown out to 35 times. Trades at a big premium to CHC now circa 20 times multiple. ambitious forecast of $5bil FUM, is it achievable in the current climate of rising yields and likely pushback by investors. HDN below issue price, their only listed fund. it hasnt ever traded above issue price since the first week.
For example, their latest proposed health/ retail fund wont get any buyers for an IPO, and will struggle to get traction as it will be a low yielding product. this isnt comparable to CHC institutional grade properties, where even at a low yield, they get snapped regardless.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)